Home » Topics » Regulatory » EMA

EMA
RSS

Alexion Pharmaceuticals receives positive opinion from EMA to extend Soliris indication

June 26, 2017

EMA's CHMP supports approval of adalimumab biosimilar Imraldi

June 26, 2017

EMA gives positive opinion to Gilead Sciences' Vosevi

June 26, 2017

EMA validates Veyvondi MAA

June 22, 2017

EMA accepts Novartis' MAA filing for erenumab

June 22, 2017

Tarix Orphan's TXA-127 granted orphan drug status in E.U. for epidermolysis bullosa

June 13, 2017

Hemophilia A gene therapy from Sangamo and Pfizer receives E.U. orphan drug designation

June 7, 2017

EMA's COMP recommends orphan medicinal product designation for Catalyst Biosciences' CB-2679d

June 1, 2017

Dasiglucagon receives positive opinion for designation as orphan medicinal product

May 30, 2017

EMA grants PRIME designation for asunercept as treatment of glioblastoma

May 30, 2017

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...